Gapping down
In reaction to disappointing earnings/guidance:
- RETA -8.5%, SEAS -5.4%, MAR -2.6%, RDN -2%, GVA -1.3%, FOLD -0.5%
Other news:
- XFOR -1.8% (files for $150 mln mixed securities shelf offering)
- HCM -1.1% (receives Scientific Advice from EMA's CHMP; plans to submit Marketing Authorization Application for Surufatinib) .
Analyst comments:
- TS -1.7% (downgraded to Underweight from Equal Weight at Barclays)
- TRUP -1.6% (downgraded to Neutral from Buy at Guggenheim)
- OLN -1.2% (downgraded to Neutral from Buy at BofA Securities)
- RYN -0.6% (downgraded to Neutral from Buy at Citigroup)